ANIP ANI PHARMACEUTICALS INC Company Mergers 8-K Filing 2024 - Debt Issuance ANI Pharmaceuticals issued $316.25 million in 2.25% Convertible Senior Notes due 2029, with net proceeds of approximately $306.8 million intended to repay existing loans and finance a pending acquisition of Alimera Sciences, Inc.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC